AAAAAA
Results:
1-19
|
Results: 19
Authors:
BARRETT JS
ANDERS GJ
Citation: Js. Barrett et Gj. Anders, CIRCULATING CURRENT AND HYSTERESIS LOSSES IN SCREENS, SHEATHS AND ARMOR OF ELECTRIC-POWER CABLES - MATHEMATICAL-MODELS AND COMPARISON WITH IEC-STANDARD-287, IEE proceedings. Science, measurement and technology, 144(3), 1997, pp. 101-110
Authors:
ROHATAGI S
BARRETT JS
MCDONALD LJ
MORRIS EM
DARNOW J
DISANTO AR
Citation: S. Rohatagi et al., SELEGILINE PERCUTANEOUS-ABSORPTION IN VARIOUS SPECIES AND METABOLISM BY HUMAN SKIN, Pharmaceutical research, 14(1), 1997, pp. 50-55
Authors:
BARRETT JS
FISHER SJ
WAHL RL
Citation: Js. Barrett et al., POSTURAL EFFECTS ON PERITONEAL TRANSPORT AND SYSTEMIC UPTAKE OF RADIOLABELED MONOCLONAL-ANTIBODIES, Cancer immunology and immunotherapy, 44(3), 1997, pp. 173-178
Authors:
CHEN S
KUMAR S
CHOU WH
BARRETT JS
WEDLUND PJ
Citation: S. Chen et al., A GENETIC BIAS IN CLINICAL-TRIALS - CYTOCHROME P450-2D6 (CYP2D6) GENOTYPE IN GENERAL VS SELECTED HEALTHY SUBJECT POPULATIONS, British journal of clinical pharmacology, 44(3), 1997, pp. 303-304
Authors:
ROHATAGI S
BARRETT JS
DEWITT KE
LESSARD D
MORALES RJ
Citation: S. Rohatagi et al., PHARMACOKINETIC EVALUATION OF A SELEGILINE PULSATILE ORAL DELIVERY SYSTEM, Biopharmaceutics & drug disposition, 18(8), 1997, pp. 665-680
Authors:
ROHATAGI S
BARRETT JS
DEWITT KE
MORALES RJ
Citation: S. Rohatagi et al., INTEGRATED PHARMACOKINETIC AND METABOLIC MODELING OF SELEGILINE AND METABOLITES AFTER TRANSDERMAL ADMINISTRATION, Biopharmaceutics & drug disposition, 18(7), 1997, pp. 567-584
Authors:
BARRETT JS
DISANTO AR
THOMFORD PJ
LARSEN EM
PALAZZOLO MJ
MORALES RJ
Citation: Js. Barrett et al., TOXICOKINETIC EVALUATION OF A SELEGILINE TRANSDERMAL SYSTEM IN THE DOG, Biopharmaceutics & drug disposition, 18(2), 1997, pp. 165-184
Authors:
BARRETT JS
HOCHADEL TJ
MORALES RJ
ROHATAGI S
DEWITT KE
WATSON SK
DARNOW J
AZZARO AJ
DISANTO AR
Citation: Js. Barrett et al., PRESSOR-RESPONSE TO TYRAMINE AFTER SINGLE 24-HOUR APPLICATION OF A SELEGILINE TRANSDERMAL SYSTEM IN HEALTHY-MALES, Journal of clinical pharmacology, 37(3), 1997, pp. 238-247
Authors:
BARRETT JS
SZEGO P
ROHATAGI S
MORALES RJ
DEWITT KE
RAJEWSKI G
IRELAND J
Citation: Js. Barrett et al., ABSORPTION AND PRESYSTEMIC METABOLISM OF SELEGILINE HYDROCHLORIDE AT DIFFERENT REGIONS IN THE GASTROINTESTINAL-TRACT IN HEALTHY-MALES, Pharmaceutical research, 13(10), 1996, pp. 1535-1540
Authors:
BARRETT JS
ROHATAGI S
DEWITT K
MORALES R
Citation: Js. Barrett et al., BIOEQUIVALENCE OF SELEGILINE HCL - GUIDANCE FOR A HIGHLY VARIABLE DRUG, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 75-75
Authors:
BARRETT JS
GREEN MA
Citation: Js. Barrett et Ma. Green, A STATISTICAL-METHOD FOR EVALUATING ELECTRICAL FAILURES, IEEE transactions on power delivery, 9(3), 1994, pp. 1524-1530
Authors:
VIELHABER JP
BARRETT JS
Citation: Jp. Vielhaber et Js. Barrett, NM-WIN - A PERSONAL COMPUTER-BASED MICROSOFT(R) WINDOWS(TM) FRONT-ENDTO NONMEM-IV, Pharmaceutical research, 11(5), 1994, pp. 709-714
Authors:
BARRETT JS
GOULD RJ
ELLIS JD
HOLAHAN MM
STRANIERI MT
LYNCH JJ
HARTMAN GD
IHLE N
DUGGAN M
MORENO OA
THEOHARIDES AD
Citation: Js. Barrett et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF L-703,014, A POTENT FIBRINOGEN RECEPTOR ANTAGONIST, AFTER INTRAVENOUS AND ORAL-ADMINISTRATION IN THE DOG, Pharmaceutical research, 11(3), 1994, pp. 426-431
Authors:
VIELHABER JP
KUHLMAN JV
BARRETT JS
Citation: Jp. Vielhaber et al., UPDATING NONMEM-IV INSTALLATION AND EXECUTION ON THE VAX-9000 - DCL PROCEDURE FOR SINGLE-STEP EXECUTION, Computer methods and programs in biomedicine, 42(1), 1994, pp. 71-72
Authors:
BARRETT JS
MURPHY G
PEERLINCK K
LEPELEIRE ID
GOULD RJ
PANEBIANCO D
HAND E
DECKMYN H
VERMYLEN J
ARNOUT J
Citation: Js. Barrett et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF MK-383, A SELECTIVE NONPEPTIDE PLATELET GLYCOPROTEIN-IIB IIIA RECEPTOR ANTAGONIST, IN HEALTHY-MEN/, Clinical pharmacology and therapeutics, 56(4), 1994, pp. 377-388
Authors:
PURI BK
ELDOSOKY A
BARRETT JS
Citation: Bk. Puri et al., SELF-INFLICTED INTRACRANIAL INJURY, British Journal of Psychiatry, 164, 1994, pp. 841-842
Authors:
GOULD RJ
BARRETT JS
ELLIS JD
HOLAHAN MA
STRANIERI MT
THEOHARIDES AD
LYNCH JJ
FRIEDMAN PA
DUGGAN ME
IHLE NC
ANDERSON PS
HARTMAN GD
Citation: Rj. Gould et al., CHARACTERIZATION OF L-703,014, A NOVEL FIBRINOGEN RECEPTOR ANTAGONIST, FOLLOWING ORAL-ADMINISTRATION TO DOGS, Thrombosis and haemostasis, 69(6), 1993, pp. 539-539
Authors:
VIELHABER JP
KUHLMAN JV
BARRETT JS
Citation: Jp. Vielhaber et al., NONMEM VERSION-III IMPLEMENTATION ON A VAX 9000 - A DCL PROCEDURE FORSINGLE-STEP EXECUTION AND THE UNREALIZED ADVANTAGE OF A VECTORIZING FORTRAN COMPILER, Computer methods and programs in biomedicine, 40(2), 1993, pp. 103-115
Authors:
GERTZ BJ
BARRETT JS
EISENHANDLER R
KRUPA DA
WITTREICH JM
SEIBOLD JR
SCHNEIDER SH
Citation: Bj. Gertz et al., GROWTH-HORMONE RESPONSE IN MAN TO L-692,429, A NOVEL NONPEPTIDE MIMICOF GROWTH HORMONE-RELEASING PEPTIDE-6, The Journal of clinical endocrinology and metabolism, 77(5), 1993, pp. 1393-1397
Risultati:
1-19
|